The results of the present study also demonstrated a worse prognosis for T and NK lymphoma patients in the high MALAT1 expression group, especially for those in the mature PTCL group, including PTCL-NOS, AITL and ALCL. The gene discussed is MALAT1; the disease is angioimmunoblastic T-cell lymphoma.